Sugar inling may be a sweet way to treat lung diseases, researchers can find it t



Sugar could go on to be a gentle way to treat lung diseases, new research is being recommended.

Scientists discovered them when investigating the effects of glucose on the cells of an immune system.

They found that 'receptor' proteins which are sensitive to sugar can inhibit the effect of arthritis, asthma, and response to parasites.

But there was an interesting side-by-the-side for the research – thinking that breathing in the sugar system could immune from the immune system.

“Supply of glucose fluids may help to protect against some lung diseases,” said the scientist Professor Andrew MacDonald, of the University of Manchester.

How sugar might be inhaled is not made clear in the study, published in the journal Nature Immunology.

Theoretically sugar could be “snorted” as a powder, but not “vaped”. When a sugar solution is heated the water evaporates while the sugar crystallises.

The study in mice looked at specialised white blood cells called macrophages. These act as immune system “vacuum cleaners”, removing harmful organisms and debris.

The Manchester team found that macrophages in the lungs need the right level of glucose “fuel” in order to function properly.

Too much sugar stimulation led to inflammation of the type often associated with chronic conditions such as asthma.

Lung inflammation is also linked to the potentially deadly effects of parasitic worm infections, a huge problem in Africa and Asia.

The research suggests that blocking sugar receptors on lung macrophages could help suppress such diseases.

On the other hand, stimulating the cells with more sugar might help the immune system fight off bronchial infections responsible for coughing fits and pneumonia.

Support freelance journalism and subscription to Independent Minds

Prof MacDonald added: “Respiratory illnesses cause terrible suffering in both the developing and developed world. Hundreds of people are admitted to hospital every day in the UK with asthma attacks, while potentially deadly parasitic infections in the lungs are endemic across much of Africa and Asia. The idea that modifying glucose levels in the lungs could one day be a critical factor in treatment of these conditions is tremendously exciting.

“Clearly we now need to study the impact of glucose on human lung macrophages.”

Press Association


Tell you what is true. You can make your own suggestion.

At The Independentand no one tells us what we can write. That is why, in a time of political and discriminatory tension of Brexit, more readers are turning to an independent repository. Subscribe from just 15p a day for others including additional events and e-books with no advertisements.

Subscribe now


Source link